About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...

Innovative Pharmaceutical Initiative – iF!

> Organisational Structure

Board of Directors

Rina Musić
— President
MSD
Schalk Opperman
— Vice President
Merck
Viktorija Zadro Huml
Takeda
Velimir Šimičević
Servier
Sandra Velasco
Novartis
Tatjana Tomljanović
Johnson & Johnson
Boris Lukovnjak
Roche

Executive Director

Sani Pogorilić
— Executive Director
iF!

Task Forces

Medical and Regulatory
Velimir Šimičević, Sponsor
Ana Pukljak, Head
Melita Drčić Duh, Secretary
Ethics and Compliance
Velimir Šimičević, Sponsor
Mate Kardoš, Secretary
Vaccines
Rina Musić, Sponsor
Vanesa Benković, Head
Žanina Jakopin, Secretary
Finance and Tax
Schalk Opperman, Sponsor
Igor Šalat, Head
Patients
Tatjana Tomljanović, Sponsor
Andreja Šantek, Head
Nikolina Škaron, Secretary
Daniela Ćutić, Secretary
EU Policies
Sandra Velasco, Sponsor
Vaccines
Rina Musić, Sponsor
Iva Jović, Head
Oncology
Boris Lukovnjak, Sponsor
Vedrana Raguž, Head
Ljiljana Vnučec, Secretary
Diabetes
Velimir Šimičević, Sponsor
Tanja Žignić, Head
Rare Diseases
Viktorija Zadro Huml, Sponsor
Vesna Tomljenović, Head
Scroll to Top

About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Start typing to search